Shelley Lees

Shelley Lees publication distribution in Social Sciences and Humanities in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Social Sciences and Humanities in 2026. The highlighted bar marks where Shelley Lees sits on this spectrum.

Shelley Lees D-index placement in Social Sciences and Humanities in 2026

The chart shows the D-index (discipline H-index) distribution of Social Sciences and Humanities scientists ranked by Research.com in 2026. The highlighted bar marks where Shelley Lees sits on this spectrum.

Overview

Best Publications

• Developing culturally competent researchers.

  Irena Papadopoulos;Shelley Lees

  320
  Citations

• Ethiopian refugees in the UK: migration, adaptation and settlement experiences and their relevance to health

  Irena Papadopoulos;Shelley Lees;Margaret Lay;Alem Gebrehiwot

  219
  Citations

• Prevalence of intimate partner violence and abuse and associated factors among women enrolled into a cluster randomised trial in northwestern Tanzania

  Saidi Kapiga;Sheila Harvey;Abdul Khalie Muhammad;Heidi Stöckl

  173
  Citations

• Behavioral Change Towards Reduced Intensity Physical Activity Is Disproportionately Prevalent Among Adults With Serious Health Issues or Self-Perception of High Risk During the UK COVID-19 Lockdown

  Nina Trivedy Rogers;Naomi R. Waterlow;Hannah Brindle;Luisa Enria

  165
  Citations

• The role of partnership dynamics in determining the acceptability of condoms and microbicides

  C M Montgomery;S Lees;J Stadler;N S Morar

  156
  Citations

• Promoting cultural competence in health care through a research based intervention in the UK.

  Irena Papadopoulos;Mary Tilki;Shelley Lees

  148
  Citations

• Trust and transparency in times of crisis: Results from an online survey during the first wave (April 2020) of the COVID-19 epidemic in the UK.

  Luisa Enria;Naomi Waterlow;Nina Trivedy Rogers;Hannah Brindle

  140
  Citations

• Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone

  Luisa Enria;Shelley Lees;Elizabeth Smout;Thomas Mooney

  132
  Citations

• Women’s income and risk of intimate partner violence: secondary findings from the MAISHA cluster randomised trial in North-Western Tanzania

  Tanya Abramsky;Shelley Lees;Heidi Stöckl;Sheila Harvey

  125
  Citations

• A Mixed Methods and Triangulation Model for Increasing the Accuracy of Adherence and Sexual Behaviour Data: The Microbicides Development Programme

  Robert Pool;Robert Pool;Catherine M. Montgomery;Neetha S. Morar;Oliver Mweemba

  119
  Citations

• Acceptability, Usability, and Views on Deployment of Peek, a Mobile Phone mHealth Intervention for Eye Care in Kenya: Qualitative Study

  Vaishali Lodhia;Sarah Karanja;Shelley Lees;Andrew Bastawrous

  98
  Citations

• How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania

  Andrew Vallely;Andrew Vallely;Shelley Lees;Shelley Lees;Charles Shagi;Stella Kasindi

  91
  Citations

• A social empowerment intervention to prevent intimate partner violence against women in a microfinance scheme in Tanzania: findings from the MAISHA cluster randomised controlled trial.

  Saidi Kapiga;Sheila Harvey;Gerry Mshana;Christian Holm Hansen

  87
  Citations

• Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.

  Muhammed O Afolabi;David Ishola;Daniela Manno;Babajide Keshinro

  85
  Citations

• Witnessing intimate partner violence and child maltreatment in Ugandan children: a cross-sectional survey

  Karen M Devries;Louise Knight;Jennifer C Child;Nambusi Kyegombe

  85
  Citations

• Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.

  David Ishola;Daniela Manno;Muhammed O Afolabi;Babajide Keshinro

  81
  Citations

• Re-framing microbicide acceptability: findings from the MDP301 trial.

  Catherine M. Montgomery;Mitzy Gafos;Shelley Lees;Neetha S. Morar

  80
  Citations

• Modelling the pandemic: attuning models to their contexts.

  Tim Rhodes;Kari Lancaster;Shelley Lees;Melissa Parker

  76
  Citations

• The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania

  Andrew Vallely;Andrew Vallely;Charles Shagi;Stella Kasindi;Nicola Desmond;Nicola Desmond

  71
  Citations

• A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa.

  Charles Shagi;Andrew Vallely;Stella Kasindi;Betty Chiduo

  64
  Citations

• Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model

  Robert Pool;Robert Pool;Catherine M. Montgomery;Neetha S. Morar;Oliver Mweemba

  60
  Citations

• "We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial.

  Angus Fayia Tengbeh;Luisa Enria;Elizabeth Smout;Thomas Mooney

  46
  Citations